Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 10/20 | 0.59 |
| ▸ | PPARG | P37231 | 8/20 | 0.55 |
| ▸ | MPC2 | O95563 | 1/20 | 0.48 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8974734 | 0.94 | FFAR1 (0.56) | FFAR1PPARGPPARA | |
| SCHEMBL8974677 | 0.93 | PPARG (0.57) | FFAR1PPARGMPC2CYP2C8CYP2C9 | |
| SCHEMBL8974989 | 0.89 | PPARG (0.56) | FFAR1PPARGMPC2CYP2C8CYP2C9 | |
| SCHEMBL8974649 | 0.87 | FFAR1 (0.53) | FFAR1PPARGPPARAMEN1ALDH1A1 | |
| SCHEMBL8975403 | 0.87 | FFAR1 (0.60) | FFAR1PPARGMPC2CYP2C8CYP2C9 | |
| SCHEMBL8975130 | 0.85 | FFAR1 (0.52) | FFAR1PPARGPPARA | |
| SCHEMBL8974550 | 0.83 | FFAR1 (0.52) | FFAR1PPARGMEN1ALDH1A1KMT2A | |
| SCHEMBL8974731 | 0.82 | FFAR1 (0.50) | FFAR1PPARGPPARAMEN1ALDH1A1 | |
| SCHEMBL8975029 | 0.82 | FFAR1 (0.50) | FFAR1PPARGMEN1ALDH1A1KMT2A | |
| SCHEMBL8975446 | 0.82 | PPARG (0.50) | FFAR1PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5578620-A | TREATMENT OF DIABETES AND HYPERLIPEMIA | SANKYO COMPANY, LIMITED (JP) | 1996-11-26 | — | — | US | disclosed |